p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
p53 overexpression increases chemosensitivity in multidrug-resistant osteosarcoma cell lines
Authors
Keywords
Osteosarcoma, p53, MDR, Apoptosis
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 77, Issue 2, Pages 349-356
Publisher
Springer Nature
Online
2015-12-23
DOI
10.1007/s00280-015-2944-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insulin-like Growth Factor-Dependent Proliferation and Survival of Triple-Negative Breast Cancer Cells: Implications for Therapy
- (2015) Zoë Davison et al. NEOPLASIA
- A universal gene carrier platform for treatment of human prostatic carcinoma by p53 transfection
- (2014) Lu Han et al. BIOMATERIALS
- p53 as a target for the treatment of cancer
- (2014) Michael J. Duffy et al. CANCER TREATMENT REVIEWS
- Ionizing Radiation-Induced Responses in Human Cells with Differing TP53 Status
- (2013) Razmik Mirzayans et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Rescue of MHC-1 Antigen Processing Machinery by Down-Regulation in Expression of IGF-1 in Human Glioblastoma Cells
- (2013) Yuexin Pan et al. PLoS One
- Chemotherapy-mediated p53-dependent DNA damage response in clear cell renal cell carcinoma: role of the mTORC1/2 and hypoxia-inducible factor pathways
- (2013) J Selvarajah et al. Cell Death & Disease
- Interleukin-6 signaling pathway in targeted therapy for cancer
- (2012) Yuqi Guo et al. CANCER TREATMENT REVIEWS
- Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy
- (2012) Cristina E Tognon et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Synthesis and Evaluation of (2-(4-Methoxyphenyl)-4-quinolinyl)(2-piperidinyl)methanol (NSC23925) Isomers To Reverse Multidrug Resistance in Cancer
- (2012) Zhenfeng Duan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- p53: The Attractive Tumor Suppressor in the Cancer Research Field
- (2010) Toshinori Ozaki et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Nanoparticles: A Promising Modality in the Treatment of Sarcomas
- (2010) Michiro Susa et al. PHARMACEUTICAL RESEARCH
- Gli2 and p53 Cooperate to Regulate IGFBP-3- Mediated Chondrocyte Apoptosis in the Progression from Benign to Malignant Cartilage Tumors
- (2009) Louisa Ho et al. CANCER CELL
- Overcoming Drug Resistance by Enhancing Apoptosis of Tumor Cells
- (2009) Pepita Gimenez-Bonafe et al. CURRENT CANCER DRUG TARGETS
- Inhibition of the Insulin-like Growth Factor-1 Receptor (IGF1R) Tyrosine Kinase as a Novel Cancer Therapy Approach
- (2009) Rongshi Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines
- (2009) Z. Duan et al. MOLECULAR CANCER THERAPEUTICS
- Loss-of-function genetic screening identifies a cluster of ribosomal proteins regulating p53 function
- (2008) Maria E. Castro et al. CARCINOGENESIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now